Answers are grounded in this paper and cite their sources.
Positive end-expiratory pressure (PEEP) is a cornerstone treatment for critically ill patients, with beneficial effects for acute respiratory distress syndrome (ARDS).In ARDS, PEEP prevents alveolar collapse during expiration and counteracts increased surface tension due to surfactant impairment, alveolar over-deflation, and superimposed pressure.These mechanisms contribute to a reduction in intrapulmonary shunting.Furthermore, alveolar recruitment maintained through PEEP may translate into a higher end-expiratory lung volume (EELV), which often leads to better compliance of the respiratory system (C RS ) and therefore a reduction in the driving pressure (DP), both of which are associated with higher survival rates [1].Moreover, alveolar stability protects against intra-tidal recruitment/derecruitment (i.e., atelectrauma) [2] and imposed mechanical stresses and inflammation (i.e., biotrauma) [3], and it reduces ventilation heterogeneity [4].Advantages of PEEP should be balanced against its potential disadvantages, namely, a reduction in cardiac output, an increase in pulmonary vascular resistance and alveolar dead space, and the risk of regional over-inflation [5].
No takes yet. Share an insight, caveat, or question.
Rezoagli et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: